Risk of placental abruption in relation to migraines and headaches

BMC Women's Health

Volumn 10, Issue , 2010, Pages

  Sanchez, Sixto E ^a   Williams, Michelle A ^b,c   Pacora, Percy N ^d   Ananth, Cande V ^e   Qiu, Chungfang ^c   Aurora, Sheena K ^f   Sorensen, Tanya K ^c  

^a UNIVERSIDAD DE SAN MARTÍN DE PORRES   (Peru)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f Swedish Headache Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEADACHE; HIGH RISK PREGNANCY; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL HISTORY; MIGRAINE; PAIN ASSESSMENT; PHYSICIAN; PLACENTAL DELIVERY; PREGNANCY; PREMATURITY; PRENATAL CARE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SOCIAL CLASS; SOLUTIO PLACENTAE; STILLBIRTH; CASE CONTROL STUDY; INTERVIEW; PATHOPHYSIOLOGY; PERU; PREGNANCY COMPLICATION; PREVALENCE; RISK FACTOR; STATISTICAL MODEL;

ABRUPTIO PLACENTAE; ADULT; CASE-CONTROL STUDIES; FEMALE; HEADACHE; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MIGRAINE DISORDERS; PERU; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77958125409     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-10-30     Document Type: Article

References (49)

1. Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol 1996, 144:881-889.
2. Younis JS, Samueloff A. Gestational vascular complications. Best Practice & Res Clin Haematol 2003, 16:135-151.
3. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006, 108:1005-1016. 10.1097/01.AOG.0000239439.04364.9a, 17012465.
4. Kayani SI, Walkinshaw SA, Preston C. Pregnancy outcome in severe placental abruption. BJOG 2003, 110:679-683. 10.1046/j.1471-0528.2003.02088.x, 12842059.
5. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol 2001, 153:332-337. 10.1093/aje/153.4.332, 11207150.
6. Hung TH, Hsieh CC, Hsu JJ, Lo LM, Chiu TH, Hsieh TT. Risk factors for placental abruption in an Asian population. Reprod Sci 2007, 14:59-65. 10.1177/1933719106298363, 17636217.
7. Ananth CV, Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. Am J Epidemiol 2007, 166:289-95. 10.1093/aje/kwm073, 17548787.
8. Arnold DL, Williams MA, Miller RS, Qiu C, Sorensen TK. Iron deficiency anemia, cigarette smoking and risk of placental abruption. J Obstet Gynaecol Res 2009, 35:446-452. 10.1111/j.1447-0756.2008.00980.x, 19527381.
9. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005, 162:79-91. 10.1176/appi.ajp.162.1.79, 15625205.
10. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 1999, 20:519529.
11. Ananth CV, Oyelese Y, Srinivas N, Yeo L, Vintzileos AM. Preterm premature rupture of membranes, intrauterine infection, and oligohydramnios: risk factors for placental abruption. Obstet Gynecol 2004, 104:71-77.
12. Ananth CV, Elsasser DA, Kinzler WL, Peltier MR, Getahun D, Leclerc D, Rozen RR. Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption. Mol Genet Metab 2007, 91:104-110. 10.1016/j.ymgme.2007.02.004, 1885454, 17376725.
13. Ananth CV, Peltier MR, Moore DF, Kinzler WL, Leclerc D, Rozen RR. Reduced folate carrier 80A→G polymorphism, plasma folate, and risk of placental abruption. Hum Genet 2008, 124:137-145. 10.1007/s00439-008-0531-7, 2574847, 18629538.
14. Zdoukopoulos N, Zintzaras E. Genetic Risk Factors for Placental Abruption: A HuGE Review and Meta-Analysis. Epidemiology 2008, 19:309-323. 10.1097/EDE.0b013e3181635694, 18277167.
15. Leonardi M, Mathers CD. Global Burden of Migraine in the Year 2000: Summary of Methods and Data Sources. GBD 2000 Working Paper, World Health Organization, Geneva 2003, http://www.who.int/evidence/bod
16. Contag SA, Mertz HL, Bushnell CD. Migraine during pregnancy: is it more than a headache?. Nat Rev Neurol 2009, 5:449-456. Epub 2009 Jul 14, 10.1038/nrneurol.2009.100, 19597515.
17. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology 1996, 47:52-59.
18. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657. 10.1046/j.1526-4610.2001.041007646.x, 11554952.
19. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006, 46:794-803. 10.1111/j.1526-4610.2006.00432.x, 16643583.
20. Rosamond W. Are migraine and coronary heart disease associated? An epidemiologic review. Headache 2004, 44(Suppl 1):S5-12. 10.1111/j.1526-4610.2004.04103.x, 15149488.
21. Tzourio C, Kittner SJ, Bousser MG, et al. Migraine and stroke in young women. Cephalalgia 2000, 20:190-199. 10.1046/j.1468-2982.2000.00041.x, 10997773.
22. Kruit MC, van Buchem MA, Hofman PAM, Bakkers JTN, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291:427-434. 10.1001/jama.291.4.427, 14747499.
23. Aube M. Migraine in pregnancy. Neurology 1999, 53:S26-S28.
24. Matharu MS, Levy MJ, Goadsby PJ. Understanding migraine in women. Practitioner 2002, 246:272-278.
25. Chen HM, Chen SF, Chen YH, Lin HC. Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia 2009, PubMed PMID: 19614685.
26. Facchinetti F, Allais G, Nappi RE, D'Amico R, Marozio L, Bertozzi L, Ornati A, Benedetto C. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009, 29:286-292. 10.1111/j.1468-2982.2008.01704.x, 19220309.
27. Adeney KL, Williams MA, Miller RS, Frederick IO, Sorensen TK, Luthy DA. Risk of preeclampsia in relation to maternal history of migraine headaches. J Mat Fetal Neonat Med 2005, 18:167-172.
28. Sanchez SE, Qiu C, Williams MA, Lam N, Sorensen TK. Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women. Am J Hypertens 2008, 21:360-364. 10.1038/ajh.2007.46, 18202669.
29. Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease?. Am J Obstet Gynecol 2007, 197:273. e1-e7.
30. Kirchmann M, Seven E, Björnsson A, Björnssdóttir G, Gulcher JR, Stefánsson K, Olesen J. Validation of the deCODE migraine questionnaire (DMQ3) for use in genetic studies. Eur J Neurol 2006, 13:1239-1244. 10.1111/j.1468-1331.2006.01491.x, 17038039.
31. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders. Cephalalgia 2004, 24(Suppl 1):S5-S12. 2, Headache Classification Subcommittee of the International Headache Society.
32. Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000, 183:759-769. 10.1067/mob.2000.106580, 10992206.
33. Wulsin L, Somoza E, Heck J. The feasibility of using the Spanish PHQ-9 to screen for depression in primary care in Honduras. Prim Care Companion J Clin Psychiatry 2002, 4:191-195. 10.4088/PCC.v04n0504, 327135, 15014707.
34. Kroenke K, Spitzer R, Williams J. Validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-13. 10.1046/j.1525-1497.2001.016009606.x, 1495268, 11556941.
35. Rothman KJ, Greenland S. Modern Epidemiology. 1998, Philadelphia, PA: Lippincott-Raven, 2.
36. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009, 339:b3914. 10.1136/bmj.b3914, 2768778, 19861375.
37. Hayashi M, Inoue T, Hoshimoto K, Negishi H, Ohkura T, Inaba N. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. Eur J Haematol 2002, 69:297-302. 10.1034/j.1600-0609.2002.02691.x, 12460234.
38. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006, 46:197-199. 10.1111/j.1526-4610.2006.00330.x, 16492227.
39. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009, 72:1864-1871. 10.1212/WNL.0b013e3181a71220, 2690985, 19470970.
40. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008, 28:49-56.
41. Tietjen GE. Migraine as a systemic vasculopathy. Cephalalgia 2009, 29:987-996. 10.1111/j.1468-2982.2009.01937.x, 19689607.
42. Zeller JA, Lindner V, Frahm K, Baron R, Deuschl G. Platelet-activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalalgia 2005, 25:536-541. 10.1111/j.1468-2982.2005.00916.x, 15955041.
43. Gargus JJ. Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism. Ann N Y Acad Sci 2009, 1151:133-156. 10.1111/j.1749-6632.2008.03572.x, 19154521.
44. Mezei Z, Kis B, Gecse A, Tajti J, Boda B, Telegdy G, Vécsei L. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets 2000, 11:222-225. 10.1080/09537100050057666, 10938901.
45. Ophoff RA, Terwindr GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the CA2+ channel gene CACNL1A4. Cell 1996, 87:543-552. 10.1016/S0092-8674(00)81373-2, 8898206.
46. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, Nappi G. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003, 23:197-205. 10.1046/j.1468-2982.2003.00480.x, 12662187.
47. Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelman J, Nyberg DA, Mahony BS. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992, 167(4 Pt 1):1032-1037.
48. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993, 168(6 Pt 1):1852-1856. discussion 1856-1857.
49. Signore C, Mills JL, Qian C, Yu K, Lam C, Epstein FH, Karumanchi SA, Levine RJ. Circulating angiogenic factors and placental abruption. Obstet Gynecol 2006, 108:338-344.